Medical Isotopes Market Size, Share, Growth, and Industry Analysis, By Type (Tc-99m, I-131, Lu-177, Mo-99, Iodine-125, Holmium-166) By Application (Nuclear Therapy, Equipment Radioactive Source, Diagnosis) Regional Forecast From 2025 To 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

MEDICAL ISOTOPES MARKET OVERVIEW

The global Medical Isotopes Market size stood at USD 0.91 billion in 2025, growing further to USD 1.79 billion by 2034 at an estimated CAGR of 7.8% from 2025 to 2034.

The United States Medical Isotopes Market size is projected at USD 0.29869 billion in 2025, the Europe Medical Isotopes Market size is projected at USD 0.27039 billion in 2025, and the China Medical Isotopes Market size is projected at USD 0.22881 billion in 2025.

The market's expansion is primarily attributable to the rise in chronic illness prevalence, the efficacy of alpha radioimmunotherapy in the treatment of specific cancers, and technological developments in nuclear imaging. Additionally, it is anticipated that during the projection period, the usage of nuclear medicines for individualized therapy will promote market expansion. Using radioactive materials for study, diagnosis, and therapy is essentially what nuclear medicine is all about. The main drivers for the market under study are raising cancer and heart disease rates. Cancer and cardiac problems can be effectively treated with nuclear medicine. Globally, there were 1,92,92,789 new cases of cancer in 2020, and by 2040, there are projected to be 2,88,87,940 new cases, according to GLOBOCAN 2020. The market is being driven by a rise in demand for nuclear medicine as a result of the usage of nuclear medicines in cancer treatments like radiation.

The increasing prevalence of cancer and heart illnesses, the expanding use of nuclear medicine, the rise in SPECT and PET applications, and the growing patient awareness of radiation and radiation therapy are the primary factors driving the growth of the nuclear medicine radioisotopes market.

KEY FINDINGS

COVID-19 IMPACT

COVID 19 Outbreaks Significantly Affected The Medical Sector

The COVID-19 outbreak has posed serious obstacles for healthcare systems around the world, whether they are in the planning, responding, or recovering stages. Inpatient and outpatient healthcare services for illnesses have been drastically reduced, and infection prevention and control strategies have been implemented, in order to largely manage these difficulties. The COVID-19 problems are still being overcome by medical practices all around the world. On the one hand, it ensures that non-COVID-related surgeries and hospitalizations are not adversely affected while on the other, healthcare professionals are responding to the epidemic. Elective operations like surgery must be delayed in hospitals and other healthcare facilities around the world. The majority of non-urgent treatments have been delayed.

LATEST TRENDS

Throughout The Forecast Period, the Cardiology Segment Is Anticipated To Have A Sizable Market Share

Over the course of the forecast, the cardiology segment is anticipated to occupy a sizable market share. The rising frequency of cardiovascular ailments and the expanding use of SPECT in the diagnosis of cardiac problems are the main factors contributing to the growth of this market. SPECT is required for an accurate diagnosis of cardiovascular illnesses such as coronary artery disease (CAD), strokes, and atrial fibrillation.

For instance, a study by the British Heart Foundation in July 2020 found that there were over 7.5 million heart disease sufferers in the UK, with nearly 170,000 fatalities per year, or an average of 460 per day or one every three minutes. Consequently, it is anticipated that early detection of CVD will increase demand for nuclear medicine, which will increase patient demand for radioisotopes.

• ~85 % of diagnostic nuclear medicine scans globally rely on Tc‑99m, underlining its dominance in imaging procedures.

• According to report, their isotope division supports production and delivery of high‑purity actinium‑225 and thorium‑227 for cancer therapeutic research

•   
•   
  

  Request a Free sample to learn more about this report

    

MEDICAL ISOTOPES MARKET SEGMENTATION

• By Type Analysis

According to type, the market can be segmented into Stable Isotopes, Radioisotopes. Stable Isotopes is anticipated to be the leading segment.

• By Application Analysis

Based on application, the market can be divided into Nuclear Therapy, Equipment Radioactive Source, and Diagnosis. Nuclear Therapy will be the leading segment.

DRIVING FACTORS

Advancement in Healthcare Systems Surpass the Market Growth

The majority of the time, hospital radioisotopes are utilized and preferred for the diagnosis and treatment of these serious illnesses. The market is anticipated to expand in the upcoming year due to a rise in the prevalence of chronic diseases among the senior population. New, simple cancer treatments have been adopted as a result of increased research and development efforts. The ability of these medicines to totally cure the condition is one of the most significant elements influencing the market's expansion. The usage of nuclear medications has had a favourable effect on the market as a whole. The market will rise as a result of the usage of various radiopharmaceutical-based diagnostic and therapeutic procedures.

• Demand for Mo‑99 was approximately 9,000 six‑day curies/week in 2015, highlighting the large scale necessity for isotopes.

• Government investment into infrastructure in Canada reached CAD 35 million over five years to support isotope and radiopharmaceutical development.

RESTRAINING FACTORS

Presence of Alternatives Of Diagnostic Methods Impede The Market Growth

MRI and CT scans, which are accessible worldwide, have also become popular in addition to the PET scan for the identification of cancer and many imaging procedures that use nuclear drugs for the detection and treatment of cardiovascular disorders. The market for nuclear medications will have slow expansion in the upcoming years due to the usage of these alternatives for the diagnosis of various ailments. MRI and CT scans are increasingly used in developing nations for the detection or diagnosis of a wide range of illnesses since they are more cost-effective than nuclear medicine. There are numerous reimbursement policies on the market that can be used to utilize these alternative methods. All of these factors will hinder the market for nuclear medicine.

• Reports show that supply disruptions from unplanned reactor outages have impacted isotope availability worldwide, threatening continuity of medical services.

• Regulatory compliance costs are rising significantly due to stricter inspection requirements, increasing barriers for new production facilities.

•   
•   
  Request a Free sample to learn more about this report

    

MEDICAL ISOTOPES MARKET REGIONAL INSIGHTS

North America Region Will Surpass the Market Growth

In the upcoming years, the market is anticipated to be dominated by the North American region. The market in the North American area will be driven by the rising investment in activities for carrying out research and development in this industry. The availability of an incredibly effective healthcare infrastructure will help fuel market expansion. Radioisotope production is now handled by a large number of facilities. In the North American region, radio isotopes are produced for both commercial and research purposes. The market for nuclear medicine is anticipated to expand throughout the projected period as a result of an increase in the region's cancer patient population.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• ORNL (Oak Ridge National Laboratory): Supports production and global distribution of actinium‑225, thorium‑227, and radium‑223 for medical research and therapies.

• NorthStar Medical Radioisotopes: Collaborates with Argonne and ORNL to develop reactor-alternative Mo‑99 and other isotopes using accelerator-based systems.

List Of Top Medical Isotopes Companies

• ORNL
• Polatom
• China National Nuclear Corporation
• NorthStar
• Niowave Inc.
• Center of Molecular Research
• LANL
• Cambridge Isotope Laboratories, Inc.
• Urenco
• Bruce Power
• Coqui RadioPharmaceuticals
• NTP Radioisotopes
• SHINE Technologies
• NRG
• IRE
• Eckert and Ziegler Strahlen

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.